In The Press

desertnews.comLetter: Cannabinoid Medicine, Dr. Roscoe Moore, Jr., March 11, 2015

Excerpt: “My work as a member of the Scientific Advisory Board of Cannabis Science, a publicly traded company researching and commercializing medicinal cannabinoids, enables me to see the research and understand the promise of medicinal cannabinoids. That’s why I support their legitimate, medically valid use.”

hivplusmag.comCould Cannabis Treat HIV?
HIVPLUSMAG.COM , February 24, 2015

Excerpt: “Cannabis Science is exploring the use of cannabinoids to treat Kaposi’s sarcoma in people with HIV as well as a potential therapy directed at inhibiting the HIV protein Tat, which is key for viral replication and modulates the expression of genes that regulate a variety of cellular activities. This would be revolutionary for people living with HIV, as chemotherapy, a primary treatment for Kaposi’s sarcoma, is largely unavailable in Africa, which has the highest burden of the disease. A cannabinoid-based antiviral would be cheaper than currently available drugs, greatly decreasing the cost of treating HIV and allowing for increased access to treatment for the nearly 7 million HIV patients around the world who need antiretroviral drugs but do not currently have access to them.”

Examiner.comQ & A with Raymond C. Dabney: A Seasoned Executive
Leading A Brand New Industry

Examiner, February 13, 2015

Excerpt: “Through drug development, medicinal characterization, and clinical research, our goal is to develop, produce, and commercialize innovative therapeutic approaches for treatment of illnesses caused by infections and age-related illness. Our initial focus is on skin cancers and neurological conditions with future endeavors to include infectious illnesses, neurobehavioral disorders including attention deficit disorder, post-traumatic stress disorder, and an application of the anti-inflammatory activities of cannabis in the management of age-related illnesses.”

Cannabinoids as Treatment
A&U America's AIDS Magazine, July 29, 2013

Excerpt: “When asked of the potential for cannabinoids to be used as treatments for diseases such as HIV, Dr. Bob Melamede, president and director of Cannabis Science, stated: 'If people are able to objectively look at the medical research on cannabis, there would likely be no debate regarding the widespread need for cannabis-based medicines.' ”

Doctor Believes More Physicians Will Recommend Medical Marijuana
KUSA, March 14, 2010

Excerpt: “Dr. Alan Shackelford has been practicing medicine for 26 years. Medicine most people would consider traditional. Shackelford was trained in internal medicine at Harvard. He currently oversees recovery, treatment and rehabilitation of patients dealing with personal injuries, including car crash. Shackelford recently decided to start recommending medical marijuana as a course of treatment for patients in his practice.”

Scientists, FDA at Odds Over Benefits of Marijuana
The Daily Camera, May 4, 2009

Excerpt: “Melamede, who teaches at the University of Colorado at Colorado Springs… is both a scholar and a patient on the state's registry, and he says the drug has the potential to benefit almost everyone: stroke patients, cancer patients, the mentally ill and possibly even soldiers exposed to chemical warfare.”

Cannabis Science, Inc. (CBIS.OB) is “One to Watch”
International Business Times, October 19, 2010

Excerpt: “Cannabis Science Inc. is an emerging cannabis pharmaceutical company that trades on the OTC Bulletin Board. They are at the forefront of medical marijuana research and development. With headquarters in Colorado Springs, California, the company works with world authorities on phytocannabinoid science targeting critical illnesses.”

Local Cannabis Company Announces Success With Cancer Treatment
The Colorado Independent, December 15, 2011

Excerpt: “While the National Institute of Health at one point noted that cannabis had a possible therapeutic effect on cancer, for the most part cancer patients using cannabis do so without the blessing of official medical science. Theirs is the science of the underground, of anecdote, of stories told by the cured, of explanations offered by doctors willing to step outside the mainstream, and of scientists like Melamede.”

Medical Marijuana as Protection Against The H1N1 Swine Flu Virus?
Digital Journal, August 3, 2009

Excerpt: “The inevitable reemergence of the virus in the cooler weather that it enjoys is further complicated by the likelihood that the world's vaccine producers will not have an adequate supply of vaccinations in time for the initial return of the virus. Unlike other seasonal influenza strains, the H1N1 swine flu virus has remained active throughout the warmer spring and summer months…With this backdrop in mind, one CEO has an alternative and controversial idea.”

Opinion: Medical Marijuana Benefits
CBS News, November 13, 2010

Excerpt: “Evidence supporting medical marijuana for appetite loss, glaucoma, nausea, vomiting, spasticity, pain, and weight loss is quite impressive. Evidence for its use for arthritis, dystonia, insomnia, seizures, and Tourette's syndrome is also very promising.”

Cannabis Smoke Less Carcinogenic Than Tobacco Smoke
Medical News Today, October 19, 2005

Excerpt: “Dr. Melamede from the University of Colorado, Colorado Springs, USA, writes that although cannabis smoke and tobacco smoke are chemically very similar, evidence suggests that their effects are very different and that cannabis smoke is less carcinogenic than tobacco smoke.”

Survey: Many Veterans, Others Use Cannabis for PTSD
Toke of the Town, February 16, 2010

Excerpt: “Many veterans and others are using cannabis medically to treat the symptoms of Post-Traumatic Stress Disorder (PTSD), according to preliminary results of a new survey. Cannabis Science Inc., which describes itself as 'an emerging pharmaceutical cannabis company,' is reviewing the interim results of its survey of more than 1,400 people.”

The Top 20 Most Influential People in the Medical Cannabis Industry
Culture, December 3, 2009

Excerpt: “RICHARD COWAN -Former president of the Young Republicans at Yale University (where he received his B.A. in economics) and former director of NORML, Cowan is an unapologetic advocate coming at medical cannabis reform from every angle.”

With “Med Pot” Raids Halted, Selling Grass Grows Greener
Wall Street Journal, July 23, 2009

Excerpt: “A pot activist named Richard Cowan has opened what he envisions as an investment bank for pot-related businesses, called General Marijuana.”